Both APHKX and BDIQX are mutual funds. APHKX has a lower 5-year return than BDIQX (5.85% vs 7.37%). Below is the comparison between APHKX and BDIQX.
APHKX | BDIQX | |
---|---|---|
Security Type | Mutual fund | Mutual fund |
Segment | International Equity: Foreign Large Blend | International Equity: Foreign Large Blend |
Family | Artisan Partners Limited Partnership | BMO Funds |
Net Assets | $15.63B | N/A |
Expense Ratio | 0.95% | N/A |
Management Style | active | active |
Dividend Yield | 3.05% | N/A |
Minimum Investment | N/A | $2,000,000.00 |
YTD Return | -8.54% | -0.57% |
1-Year Return | -8.71% | 0.40% |
3-Year Return | 9.87% | 8.09% |
5-Year Return | 5.85% | 7.37% |
10-Year Return | 9.63% | N/A |
APHKX
APHKX description
The Fund seeks maximum long-term capital growth by investing in a portfolio of undervalued non-U.S. companies.
APHKX performance & returns
YTD Return | -8.54% |
1-Month Return | -5.51% |
3-Month Return | -8.71% |
1-Year Return | -8.71% |
3-Year Return | 9.87% |
5-Year Return | 5.85% |
10-Year Return | 9.63% |
APHKX holdings
Top 10 Holdings (41.48% of Total Assets)
Name | Symbol | % Assets |
---|---|---|
Samsung Electronics Co Ltd | 005930.KS | 6.01% |
ABB Ltd | ABBN | 5.19% |
Compass Group PLC | CPG.L | 4.76% |
NAVER Corp | 035420.KS | 4.28% |
Arch Capital Group Ltd | ACGL | 3.81% |
UBS Group AG | UBSG | 3.79% |
Fresenius Medical Care AG & Co. KGaA | FME.DE | 3.58% |
Novartis AG | NOVN | 3.46% |
HCL Technologies Ltd | HCLTECH.BO | 3.30% |
Cie Financiere Richemont SA | CFR | 3.30% |
APHKX pros
The following are APHKX strengths from our perspective:
- APHKX 3-year return is 9.87%, which is higher than the 3-year return of the benchmark index (MSCI EAFE NR USD), 4.46%.
- APHKX 5-year return is 5.85%, which is higher than the 5-year return of the benchmark index (MSCI EAFE NR USD), 3.54%.
- APHKX 10-year return is 9.63%, which is higher than the 10-year return of the benchmark index (MSCI EAFE NR USD), 6.6%.
- APHKX 15-year return is 6.25%, which is higher than the 15-year return of the benchmark index (MSCI EAFE NR USD), 1.91%.
- Good news: this fund does not have 12b1, front-end or back-end sales fees.
APHKX cons
The following are APHKX weaknesses from our perspective:
- APHKX expense ratio is 0.95%, which is not negligible. Is the fund expensive to you, and does it align to your investment strategy?
Other relevant APHKX comparisons
You may also want to check out the following APHKX comparisons that investors often look for on Finny
- APHKX vs VGTSX
- APHKX vs VTIAX
- APHKX vs DODFX
- APHKX vs VTSNX
- APHKX vs VTPSX
- APHKX vs VTMGX
- APHKX vs VDIPX
- APHKX vs VTMNX
- APHKX vs VTISX
- APHKX vs TCIEX
BDIQX
BDIQX description
null
BDIQX performance & returns
YTD Return | -0.57% |
1-Month Return | 1.87% |
3-Month Return | 0.40% |
1-Year Return | 0.40% |
3-Year Return | 8.09% |
5-Year Return | 7.37% |
10-Year Return | N/A |
BDIQX holdings
Top 10 Holdings (28.02% of Total Assets)
Name | Symbol | % Assets |
---|---|---|
Roche Holding AG Dividend Right Cert. | ROG | 3.45% |
BMO Institutional Prime MMkt Prem | BPFXX | 3.37% |
NTT DOCOMO Inc | 9437 | 2.89% |
Enel SpA | ENEL.MI | 2.83% |
Koninklijke Ahold Delhaize NV | AD | 2.71% |
BHP Group Ltd | BHP.AX | 2.70% |
Novartis AG | NOVN | 2.64% |
Nestle SA | NESN | 2.51% |
GlaxoSmithKline PLC | GSK.L | 2.49% |
Rio Tinto PLC | RIO.L | 2.43% |
BDIQX pros
The following are BDIQX strengths from our perspective:
- Good news: this fund does not have 12b1, front-end or back-end sales fees.
BDIQX cons
The following are BDIQX weaknesses from our perspective:
- BDIQX net assets are $0.00 million. This fund is not a popular choice with retail investors.
Other relevant BDIQX comparisons
You may also want to check out the following BDIQX comparisons that investors often look for on Finny
- BDIQX vs VGTSX
- BDIQX vs VTIAX
- BDIQX vs DODFX
- BDIQX vs VTSNX
- BDIQX vs VTPSX
- BDIQX vs VTMGX
- BDIQX vs APHKX
- BDIQX vs VDIPX
- BDIQX vs VTMNX
- BDIQX vs VTISX